What is Rex American Res's earnings per share (EPS)?

Rex American Res (REX) reported diluted earnings per share of $3.30 for fiscal year 2025. This represents a -4.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Rex American Res Financials

REX

Source SEC Filings (10-K/10-Q) Updated Oct 31, 2025 Currency USD FYE January

This page shows Rex American Res (REX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 52/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Growth

Rex American Res's revenue declined 22.9% year-over-year, from $833.4M to $642.5M. This contraction results in a growth score of 0/100.

Leverage

Rex American Res carries a low D/E ratio of 0.29, meaning only $0.29 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 96/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

100

With a current ratio of 9.37, Rex American Res holds $9.37 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 100/100.

Cash Flow

While Rex American Res generated $64.2M in operating cash flow, capex of $71.3M consumed most of it, leaving -$7.1M in free cash flow. This results in a low score of 22/100, reflecting heavy capital investment rather than weak cash generation.

Returns

Rex American Res's ROE of 13.3% shows moderate profitability relative to equity, earning a score of 41/100. This is up from 11.6% the prior year.

Piotroski F-Score Neutral

6/9

Rex American Res passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Mixed

0.90x

For every $1 of reported earnings, Rex American Res generates $0.90 in operating cash flow ($64.2M OCF vs $71.5M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$642.5M

YoY-22.9%

5Y CAGR+9.0%

10Y CAGR+1.2%

Rex American Res generated $642.5M in revenue in fiscal year 2025. This represents a decrease of 22.9% from the prior year.

EBITDA

N/A

Net Income

$71.5M

YoY+17.3%

5Y CAGR+57.3%

10Y CAGR-2.0%

Rex American Res reported $71.5M in net income in fiscal year 2025. This represents an increase of 17.3% from the prior year.

EPS (Diluted)

$3.30

YoY-4.9%

10Y CAGR-11.1%

Rex American Res earned $3.30 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 4.9% from the prior year.

Cash & Balance Sheet

Free Cash Flow

-$7.1M

YoY-107.9%

Rex American Res generated -$7.1M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 107.9% from the prior year.

Cash & Debt

$159.9M

YoY-30.8%

5Y CAGR-0.5%

10Y CAGR+1.2%

Rex American Res held $159.9M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

17M

YoY-2.8%

5Y CAGR+22.0%

10Y CAGR+8.0%

Rex American Res had 17M shares outstanding in fiscal year 2025. This represents a decrease of 2.8% from the prior year.

Margins & Returns

Gross Margin

14.2%

YoY+2.4pp

5Y CAGR+9.4pp

10Y CAGR-10.6pp

Rex American Res's gross margin was 14.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 2.4 percentage points from the prior year.

Operating Margin

N/A

Net Margin

11.1%

YoY+3.8pp

5Y CAGR+9.3pp

10Y CAGR-4.1pp

Rex American Res's net profit margin was 11.1% in fiscal year 2025, showing the share of revenue converted to profit. This is up 3.8 percentage points from the prior year.

Return on Equity

13.3%

YoY+1.7pp

5Y CAGR+11.4pp

10Y CAGR-11.3pp

Rex American Res's ROE was 13.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 1.7 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

$14.7M

10Y CAGR-2.1%

Rex American Res spent $14.7M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Capital Expenditures

$71.3M

YoY+89.4%

5Y CAGR+80.0%

10Y CAGR+21.8%

Rex American Res invested $71.3M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 89.4% from the prior year.

REX Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$642.5M-22.9%	$833.4M-2.5%	$855.0M+10.4%	$774.8M+107.9%	$372.7M-10.8%	$417.7M
Cost of Revenue	$551.0M-25.0%	$735.2M-8.8%	$806.4M+17.9%	$684.2M+93.7%	$353.1M-11.1%	$397.3M
Gross Profit	$91.5M-6.9%	$98.2M+102.1%	$48.6M-46.4%	$90.6M+364.0%	$19.5M-4.3%	$20.4M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$27.1M-7.6%	$29.4M+28.7%	$22.8M+6.0%	$21.5M+22.1%	$17.6M-9.7%	$19.5M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	$21.4M-5.2%	$22.6M+136.4%	$9.5M-49.9%	$19.0M+3585.5%	-$546K+72.5%	-$2.0M
Net Income	$71.5M+17.3%	$60.9M+120.0%	$27.7M-47.1%	$52.4M+1644.9%	$3.0M-59.6%	$7.4M
EPS (Diluted)	$3.30-4.9%	$3.47+121.0%	$1.57-46.2%	$2.92	N/A	N/A

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Revenue	$175.6M+10.8%	$158.6M+0.1%	$158.3M+0.1%	$158.2M-9.5%	$174.9M+18.0%	$148.2M-8.1%	$161.2M-14.1%	$187.6M
Cost of Revenue	$139.5M-3.3%	$144.2M+0.2%	$144.0M+2.4%	$140.7M+4.0%	$135.2M+5.3%	$128.4M-12.5%	$146.8M-6.6%	$157.2M
Gross Profit	$36.1M+152.3%	$14.3M-0.2%	$14.3M-18.4%	$17.6M-55.7%	$39.7M+100.7%	$19.8M+36.8%	$14.5M-52.5%	$30.4M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$8.2M+32.5%	$6.2M+4.3%	$5.9M-3.7%	$6.2M-26.8%	$8.4M+30.8%	$6.4M+5.4%	$6.1M-17.2%	$7.4M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	$8.0M+188.5%	$2.8M-6.3%	$3.0M-22.4%	$3.8M-59.5%	$9.4M+109.4%	$4.5M+21.7%	$3.7M-48.5%	$7.2M
Net Income	$27.5M+194.5%	$9.3M-12.6%	$10.7M-24.3%	$14.1M-53.2%	$30.1M+100.6%	$15.0M+22.3%	$12.3M-18.2%	$15.0M
EPS (Diluted)	$0.71+65.1%	$0.43-15.7%	$0.51	N/A	$0.69-1.4%	$0.70+20.7%	$0.58	N/A

REX Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$693.8M+3.4%	$671.0M+18.4%	$566.5M+3.4%	$548.0M+12.7%	$486.1M+2.1%	$476.0M
Current Assets	$398.8M-5.4%	$421.6M+16.8%	$361.0M+5.3%	$342.9M+27.1%	$269.8M+9.2%	$247.1M
Cash & Equivalents	$159.9M-30.8%	$231.2M+197.7%	$77.7M+16.5%	$66.7M-57.6%	$157.1M-4.1%	$163.8M
Inventory	$30.5M+12.6%	$27.1M-34.4%	$41.3M-26.8%	$56.4M+111.3%	$26.7M-2.1%	$27.3M
Accounts Receivable	$28.0M+29.9%	$21.5M-26.3%	$29.2M+14.8%	$25.4M-7.7%	$27.6M+894.1%	$2.8M
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$157.5M+7.4%	$146.6M+29.8%	$112.9M+0.8%	$112.0M+19.8%	$93.5M+8.1%	$86.5M
Current Liabilities	$42.6M-32.1%	$62.7M+73.3%	$36.2M-6.9%	$38.9M+31.2%	$29.6M+49.1%	$19.9M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$536.4M+2.3%	$524.5M+15.6%	$453.6M+4.0%	$436.0M+11.1%	$392.6M+0.8%	$389.5M
Retained Earnings	$768.6M+8.0%	$712.0M+10.2%	$646.1M-0.2%	$647.5M+8.3%	$597.8M+3.2%	$579.4M

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Total Assets	$750.1M+7.1%	$700.6M+1.0%	$693.8M-3.6%	$720.0M+0.6%	$715.7M+5.2%	$680.0M+1.3%	$671.0M+0.9%	$664.8M
Current Assets	$411.7M+5.4%	$390.5M-2.1%	$398.8M-8.5%	$435.8M-0.2%	$436.5M+4.2%	$418.9M-0.6%	$421.6M-6.7%	$452.1M
Cash & Equivalents	$272.0M+12.9%	$241.0M+50.7%	$159.9M-18.5%	$196.3M-34.2%	$298.2M+14.3%	$261.0M+12.9%	$231.2M+3.5%	$223.4M
Inventory	$27.7M-12.5%	$31.6M+3.7%	$30.5M-3.7%	$31.7M+8.8%	$29.1M-0.1%	$29.2M+7.6%	$27.1M+0.4%	$27.0M
Accounts Receivable	$27.4M+10.5%	$24.8M-11.3%	$28.0M+30.1%	$21.5M-3.7%	$22.3M-8.0%	$24.3M+12.7%	$21.5M-7.1%	$23.2M
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$183.1M+18.3%	$154.8M-1.7%	$157.5M-1.4%	$159.7M+5.6%	$151.2M+7.7%	$140.4M-4.2%	$146.6M-2.9%	$150.9M
Current Liabilities	$57.5M+55.0%	$37.1M-12.9%	$42.6M-15.6%	$50.4M+14.7%	$44.0M-15.3%	$51.9M-17.2%	$62.7M-5.4%	$66.3M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$566.9M+3.9%	$545.8M+1.7%	$536.4M-4.3%	$560.3M-0.7%	$564.5M+4.6%	$539.6M+2.9%	$524.5M+2.1%	$513.9M
Retained Earnings	$566.6M-27.0%	$775.7M+0.9%	$768.6M+37.3%	$560.0M-25.2%	$748.8M+3.4%	$724.3M+1.7%	$712.0M+1.5%	$701.8M

REX Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$64.2M-49.8%	$128.0M+133.5%	$54.8M-40.3%	$91.7M+963.6%	$8.6M-16.6%	$10.3M
Capital Expenditures	$71.3M+89.4%	$37.7M+141.8%	$15.6M+203.9%	$5.1M-50.8%	$10.4M+175.7%	$3.8M
Free Cash Flow	-$7.1M-107.9%	$90.3M+130.3%	$39.2M-54.7%	$86.6M+4939.9%	-$1.8M-127.2%	$6.6M
Investing Cash Flow	-$72.9M-356.5%	$28.4M+114.3%	-$198.5M-3849.7%	$5.3M+125.5%	-$20.8M-44.1%	-$14.4M
Financing Cash Flow	-$18.5M-327.4%	-$4.3M+74.6%	-$17.0M-53.3%	-$11.1M+50.6%	-$22.4M-467.9%	-$4.0M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$14.7M	N/A	$13.0M+96.3%	$6.6M-66.2%	$19.6M	N/A

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Operating Cash Flow	$51.2M+214.7%	$16.3M+568.5%	-$3.5M-113.9%	$25.1M-24.9%	$33.4M+319.0%	$8.0M+452.2%	-$2.3M-103.6%	$62.5M
Capital Expenditures	$26.7M+21.4%	$22.0M+219.2%	$6.9M-56.6%	$15.9M+4.5%	$15.2M-1.2%	$15.4M-38.0%	$24.8M+62.3%	$15.3M
Free Cash Flow	$24.5M+527.0%	-$5.7M+44.7%	-$10.4M-212.8%	$9.2M-49.4%	$18.2M+345.3%	-$7.4M+72.6%	-$27.1M-157.4%	$47.2M
Investing Cash Flow	-$20.1M-130.5%	$65.7M+3533.2%	$1.8M+101.6%	-$110.5M-2963.9%	$3.9M-82.4%	$21.9M+83.9%	$11.9M-87.0%	$91.7M
Financing Cash Flow	-$119K+87.6%	-$959K+97.2%	-$34.7M-109.0%	-$16.6M-35197.9%	-$47K-487.5%	-$8K+99.6%	-$1.8M+49.3%	-$3.6M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$0-100.0%	$712K-97.8%	$32.7M	N/A	N/A	N/A	N/A	N/A

REX Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	14.2%+2.4pp	11.8%+6.1pp	5.7%-6.0pp	11.7%+6.5pp	5.2%+0.4pp	4.9%
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	11.1%+3.8pp	7.3%+4.1pp	3.2%-3.5pp	6.8%+5.9pp	0.8%-1.0pp	1.8%
Return on Equity	13.3%+1.7pp	11.6%+5.5pp	6.1%-5.9pp	12.0%+11.3pp	0.8%-1.1pp	1.9%
Return on Assets	10.3%+1.2pp	9.1%+4.2pp	4.9%-4.7pp	9.6%+8.9pp	0.6%-0.9pp	1.6%
Current Ratio	9.37+2.6	6.72-3.2	9.97+1.2	8.82-0.3	9.11-3.3	12.44
Debt-to-Equity	0.29+0.0	0.28+0.0	0.250.0	0.26+0.0	0.24+0.0	0.22
FCF Margin	-1.1%-11.9pp	10.8%+6.2pp	4.6%-6.6pp	11.2%+11.7pp	-0.5%-2.0pp	1.6%

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Gross Margin	20.6%+11.5pp	9.0%-0.0pp	9.1%-2.1pp	11.1%-11.6pp	22.7%+9.3pp	13.4%+4.4pp	9.0%-7.2pp	16.2%
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	15.6%+9.8pp	5.9%-0.9pp	6.7%-2.2pp	8.9%-8.3pp	17.2%+7.1pp	10.1%+2.5pp	7.6%-0.4pp	8.0%
Return on Equity	4.9%+3.1pp	1.7%-0.3pp	2.0%-0.5pp	2.5%-2.8pp	5.3%+2.6pp	2.8%+0.4pp	2.3%-0.6pp	2.9%
Return on Assets	3.7%+2.3pp	1.3%-0.2pp	1.5%-0.4pp	2.0%-2.3pp	4.2%+2.0pp	2.2%+0.4pp	1.8%-0.4pp	2.3%
Current Ratio	7.16-3.4	10.53+1.2	9.37+0.7	8.64-1.3	9.93+1.9	8.07+1.3	6.72-0.1	6.82
Debt-to-Equity	0.32+0.0	0.280.0	0.290.0	0.28+0.0	0.270.0	0.26-0.0	0.28-0.0	0.29
FCF Margin	14.0%+17.6pp	-3.6%+2.9pp	-6.6%-12.4pp	5.8%-4.6pp	10.4%+15.4pp	-5.0%+11.8pp	-16.8%-42.0pp	25.2%

Similar Companies

Braskem Sa BAK

$1.4B

Westlake Chem Partners Lp WLKP

$780.0M

ASP Isotopes ASPI

$536.7M

Tronox Holdings Plc TROX

$1.5B

Green Plains GPRE

$1.2B

Frequently Asked Questions

What is Rex American Res's annual revenue?

Rex American Res (REX) reported $642.5M in total revenue for fiscal year 2025. This represents a -22.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Rex American Res's revenue growing?

Rex American Res (REX) revenue declined by 22.9% year-over-year, from $833.4M to $642.5M in fiscal year 2025.

Is Rex American Res profitable?

Yes, Rex American Res (REX) reported a net income of $71.5M in fiscal year 2025, with a net profit margin of 11.1%.

What is Rex American Res's gross margin?

Rex American Res (REX) had a gross margin of 14.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Rex American Res's net profit margin?

Rex American Res (REX) had a net profit margin of 11.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Rex American Res's return on equity (ROE)?

Rex American Res (REX) has a return on equity of 13.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Rex American Res's free cash flow?

Rex American Res (REX) generated -$7.1M in free cash flow during fiscal year 2025. This represents a -107.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Rex American Res's operating cash flow?

Rex American Res (REX) generated $64.2M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Rex American Res's total assets?

Rex American Res (REX) had $693.8M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Rex American Res's capital expenditures?

Rex American Res (REX) invested $71.3M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does Rex American Res buy back shares?

Yes, Rex American Res (REX) spent $14.7M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Rex American Res have outstanding?

Rex American Res (REX) had 17M shares outstanding as of fiscal year 2025.

What is Rex American Res's current ratio?

Rex American Res (REX) had a current ratio of 9.37 as of fiscal year 2025, which is generally considered healthy.

What is Rex American Res's debt-to-equity ratio?

Rex American Res (REX) had a debt-to-equity ratio of 0.29 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Rex American Res's return on assets (ROA)?

Rex American Res (REX) had a return on assets of 10.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Rex American Res's Piotroski F-Score?

Rex American Res (REX) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Rex American Res's earnings high quality?

Rex American Res (REX) has an earnings quality ratio of 0.90x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Rex American Res?

Rex American Res (REX) scores 52 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.